Assessing and communicating heterogeneity of treatment effects for patient subpopulations: Keynote and panel discussion on communicating heterogeneous treatment effects across populations.

Heyward, James; Lolic, Milena; Spong, Catherine; Atkins, David; Pennello, Gene; Varadhan, Ravi

Heyward, James; Lolic, Milena; Spong, Catherine; Atkins, David; Pennello, Gene; Varadhan, Ravi.

Afiliación

Heyward J; Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Lolic M; Office of the Center Director, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Spong C; Department of Obstetrics and Gynecology, UT Southwestern Medical Center, Dallas, Texas, USA.
Atkins D; Health Services Research and Development Service, U.S. Department of Veterans Affairs, Washington, District of Columbia, USA.
Pennello G; Division of Biostatistics, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Varadhan R; Division of Biostatistics and Bioinformatics, Department of Oncology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.

Pharm Stat ; 20(5): 965-978, 2021 09.

Article en En | MEDLINE | ID: mdl-33942971

Palabras clave

clinical trials; drug trial snapshot; subgroup analysis; treatment effects

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Pharm Stat Asunto de la revista: FARMACOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google